Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes
Steven Daniel Funk1, Arif Yurdagul, A Wayne Orr
1Departments of Cell Biology and Anatomy and Pathology, LSU Health Sciences Center, Shreveport, LA 71130, USA.
International Journal of Vascular Medicine
|April 11, 2012
Summary
High blood sugar (hyperglycemia) in diabetes independently drives plaque formation by altering endothelial cell function. This research clarifies how diabetes directly impacts cardiovascular disease development.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Cell Biology
Background:
- Diabetes and cardiovascular disease (CVD) have a long-established link.
- Mechanisms of diabetes-induced atherosclerosis are complex, confounded by metabolic syndrome components in type 2 diabetes.
- Hyperglycemia is a key factor in diabetes, independently influencing atherosclerosis.
Purpose of the Study:
- To elucidate the specific mechanisms by which hyperglycemia promotes atherosclerotic plaque formation.
- To highlight the role of endothelial cell biology in diabetes-related atherogenesis.
Main Methods:
- Review of existing literature on hyperglycemia, endothelial cells, and atherosclerosis.
- Analysis of data from cell culture systems, animal models, and human patient studies.
Main Results:
- Hyperglycemia directly impacts atherogenesis across various models.
- Endothelial cell dysfunction is a critical pathway through which hyperglycemia promotes plaque buildup.
- Hyperglycemia affects endothelial functions including permeability, inflammation, and thrombosis.
Conclusions:
- Hyperglycemia is a significant independent driver of atherosclerosis in diabetic patients.
- Understanding hyperglycemia's effects on endothelial cells is crucial for preventing diabetes-related CVD.
- Targeting endothelial cell pathways affected by high blood sugar may offer therapeutic strategies.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...